// company-profile

Atea Pharmaceuticals, Inc.

AVIR
ExchangeNasdaqSectorPharmaceutical PreparationsInc.MAFilings52Insiders14
// api This Atea Pharmaceuticals, Inc. insider-trading data is served live by the Form4API insider trading API. Get the same data via API.

// activity-summary

No insider transactions in the last 30 days.

// 90-day insight

Over the last 90 days, Atea Pharmaceuticals, Inc. insiders bought $25K across 1 transaction with no open-market sales.

  • Most active insider: Murphy Polly A. with 1 transaction totaling $25K.
  • Largest single purchase: $25K by Murphy Polly A. on May 18, 2026.

Activity skews bullish — buys outpace sales.

Institutional Ownership

Top 13F-HR holders of Atea Pharmaceuticals, Inc. as of 2026-03-31

↑ increasing
Total reported AUM
$303.5M
QoQ change
+80.7%
Reporting period
2026-03-31
#1
BML Capital Management, LLC
CIK 1616824
$38.0M
7.1M shares
#2
FMR LLC
CIK 315066
$35.2M
6.5M shares
#3
FMR LLC
CIK 315066
$29.1M
5.4M shares

Data source: SEC Form 13F-HR filings. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →

Insider Transactions

Sourced from SEC EDGAR Form 4 filings. Updated hourly.

DateInsiderCompanyTypeSharesPriceValue
May 18, 2026Murphy Polly A.AVIR
Purchase
6,100$4.17$25K
Mar 11, 2026Corcoran AndreaAVIR
Option Exercise
60,000$1.24$74K
Mar 11, 2026Corcoran AndreaAVIR
Option Exercise
60,000$0.00$0K
Feb 3, 2026Sommadossi Jean-PierreAVIR
Option Exercise
300,000$1.24$372K
Feb 3, 2026Sommadossi Jean-PierreAVIR
Option Exercise
300,000$0.00$0K

45 more transactions hidden

Free account · No credit card required

Building something? Get API access →

Popular companies on Form4API

Browse insider trading activity for other actively-filed companies.